Home Contact Login Register Search
Edited by WJM Office
Researchers worldwide are working around the clock to develop vaccines against the coronavirus.
Candidate Sponsor Trial Phase Institution Inactivated vaccine Wuhan Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) 3 Henan Provincial Center for Disease Control and Prevention CoronaVac Sinovac 3 Sinovac Research and Development Co., Ltd. mRNA-1273 Moderna 3 Kaiser Permanente Washington Health Research Institute Bacillus Calmette-Guerin (BCG) live-attenuated vaccine University of Melbourne and Murdoch Children’s Research Institute; Radboud University Medical Center; Faustman Lab at Massachusetts General Hospital 2/3 University of Melbourne and Murdoch Children’s Research Institute; Radboud University Medical Center; Faustman Lab at Massachusetts General Hospital AZD1222 The University of Oxford; AstraZeneca; IQVIA 2/3 The University of Oxford, the Jenner Institute BNT162 Pfizer, BioNTech 2/3 Multiple study sites in Europe and North America Ad5-nCoV CanSino Biologics 2 Tongji Hospital; Wuhan, China Adjuvant recombinant vaccine candidate Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences 2 BBIBP-CorV Beijing Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) 1/2 Henan Provincial Center for Disease Control and Prevention GX-19 Genexine 1/2 More Vaccine
Candidate
Sponsor
Trial Phase
Institution
Inactivated vaccine
Wuhan Institute of Biological Products; China National Pharmaceutical Group (Sinopharm)
3
Henan Provincial Center for Disease Control and Prevention
CoronaVac
Sinovac
Sinovac Research and Development Co., Ltd.
mRNA-1273
Moderna
Kaiser Permanente Washington Health Research Institute
Bacillus Calmette-Guerin (BCG) live-attenuated vaccine
University of Melbourne and Murdoch Children’s Research Institute; Radboud University Medical Center; Faustman Lab at Massachusetts General Hospital
2/3
AZD1222
The University of Oxford; AstraZeneca; IQVIA
The University of Oxford, the Jenner Institute
BNT162
Pfizer, BioNTech
Multiple study sites in Europe and North America
Ad5-nCoV
CanSino Biologics
2
Tongji Hospital; Wuhan, China
Adjuvant recombinant vaccine candidate
Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences
BBIBP-CorV
Beijing Institute of Biological Products; China National Pharmaceutical Group (Sinopharm)
1/2
GX-19
Genexine
More Vaccine
WJM CASE REPORT
Case report template
How to write a clinical case report